Loading...
Market
Story
China's HMPV Surge Strains Healthcare, No Vaccine Available
Jan 6, 2025, 11:00 PM
China is experiencing a surge in cases of human metapneumovirus (HMPV), a respiratory illness that has raised concerns due to its rapid spread and strain on the country's healthcare system. HMPV, first identified in 2001, typically causes mild respiratory symptoms but can lead to severe illness in young children and the elderly. The Centers for Disease Control and Prevention (CDC) in the U.S. is monitoring the situation in China, although HMPV cases in the U.S. remain at typical pre-pandemic levels. The virus is known to cause symptoms similar to the common cold or influenza, and can lead to complications such as bronchitis or pneumonia. There is currently no vaccine or specific treatment for HMPV, but preventive measures such as good hygiene and avoiding close contact with sick individuals are recommended.
View original story
Similar markets
Contained • 25%
Resolved • 25%
Stable • 25%
Worsening • 25%
Increase • 25%
Data not available • 25%
Stable • 25%
Decrease • 25%
Children • 25%
General population • 25%
Elderly • 25%
Immunocompromised • 25%
Less than 20 • 25%
More than 100 • 25%
20 to 50 • 25%
51 to 100 • 25%
51-100 • 25%
0-50 • 25%
More than 200 • 25%
101-200 • 25%
Zhejiang • 25%
Shanghai • 25%
Other • 25%
Beijing • 25%
Elderly (65+) • 25%
Children (0-14) • 25%
Young Adults (15-44) • 25%
Adults (45-64) • 25%
19-64 years • 25%
5-18 years • 25%
Children under 5 • 25%
65 and older • 25%
